Maven Securities LTD Agios Pharmaceuticals, Inc. Transaction History

Maven Securities LTD

  • $774 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$33.87 - $55.93 $10.2 Million - $16.8 Million
-300,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$34.45 - $53.48 $10.3 Million - $16 Million
300,000 New
300,000 $16 Million
Q1 2020

May 15, 2020
SELL
$31.52 - $53.81 $7.09 Million - $12.1 Million
-225,000 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$30.08 - $50.59 $6.77 Million - $11.4 Million
225,000 New
225,000 $10.8 Million

Others Institutions Holding AGIO

# of Institutions
232
Shares Held
58.1M
Call Options Held
403K
Put Options Held
469K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.26B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email